Olmesartan medoxomil Amlodipine and Hydrochlorothiazide

NDC 33342-244 · Macleods Pharmaceuticals Limited

Generic nameOlmesartan medoxomil Amlodipine and Hydrochlorothiazide

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE

Strength5; 12.5; 40 mg/1; mg/1; mg/1

Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]

Marketing categoryANDA

Packages

33342-244-07 — 30 TABLET, FILM COATED in 1 BOTTLE (33342-244-07)

33342-244-10 — 90 TABLET, FILM COATED in 1 BOTTLE (33342-244-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

33342-174 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 33342-175 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 33342-178 — Olmesartan medoxomil, 33342-179 — Olmesartan medoxomil, 33342-180 — Olmesartan medoxomil, 33342-190 — AMLODIPINE and OLMESARTAN medoxomil, 33342-191 — AMLODIPINE and OLMESARTAN medoxomil, 33342-192 — AMLODIPINE and OLMESARTAN medoxomil, 33342-193 — AMLODIPINE and OLMESARTAN medoxomil, 33342-243 — Olmesartan medoxomil Amlodipine and Hydrochlorothiazide, 33342-245 — Olmesartan medoxomil Amlodipine and Hydrochlorothiazide, 33342-246 — Olmesartan medoxomil Amlodipine and Hydrochlorothiazide, 33342-247 — Olmesartan medoxomil Amlodipine and Hydrochlorothiazide, 33342-279 — amlodipine and valsartan, 33342-280 — amlodipine and valsartan, 33342-281 — amlodipine and valsartan, 33342-282 — amlodipine and valsartan, 33342-283 — amlodipine,valsartan and hydrochlorothiazide, 33342-284 — amlodipine,valsartan and hydrochlorothiazide, 33342-285 — amlodipine,valsartan and hydrochlorothiazide, +1450 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels